Image

Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA

Study on whey protein milk for infants with mild to moderate CMPA.

Recruiting
3-11 years
All
Phase 4
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates how well infants with mild to moderate Cow's Milk Protein Allergy (CMPA) tolerate a special milk called Nutribaby Royal Pepti Junior (NR Pepti). CMPA means a child's body reacts badly to proteins found in cow's milk. This special milk has proteins broken down into smaller parts, which may be easier to digest.

Key Points:

  • Duration: The study involves regular use of NR Pepti.
  • Participation: Infants aged 3-11 months, with specific symptoms, can join.
  • Commitment: Parents must follow the study's feeding guidelines.

Doctors from the Indonesian Pediatric Society will work with local pediatricians to find eligible infants. The study will ensure the special milk is safe and effective for these infants, and parents must agree to stop other formulas and limit breastfeeding to a maximum of two times a day. Infants with other health issues like lactose intolerance or certain genetic conditions can't participate.

Print
Study details
    Mild to Moderate Cows' Milk Protein Allergy

NCT06204770

Danone Specialized Nutrition Indonesia

24 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.